Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial
Andreas Münch(Linköping University), Magnus Ström(Linköping University), Søren Avnstrøm(Amager Hospital), Jiřı́ Stehlı́k(Western Regional Hospital), Erik Hertervig(Lund University), Johan Bohr(Örebro University Hospital), Ralph Müeller(Dr Falk Pharma (Germany)), Martin Rössle(University Hospital Bonn), Greger Lindberg(Karolinska Institutet), Jan Björk(Karolinska University Hospital), Curt Tysk(Örebro University Hospital), Ole K. Bonderup(Aarhus University), Martin Olesen(Lund University), Cecilia Benoni(Malmö University), Per M. Hellström(Uppsala University), Stephan Miehlke(University Medical Center Hamburg-Eppendorf), Annika Lapidus(Ersta sjukhus), Roland Greinwald(Dr Falk Pharma (Germany)), Åke Öst(Synlab Czech (Czechia)), Karin Dilger(Dr Falk Pharma (Germany)), Lars Strandberg(Western Regional Hospital), Robert Löfberg(Karolinska Institutet), Peter Armerding(Pathodiagnostik Berlin)
Cited by 84
Related Papers
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
|PubMed|1991|765
World Gastroenterology Organisation Global Guideline
|Journal of Clinical Gastroenterology|2011|539
A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites
|New England Journal of Medicine|2000|523
Incidence in Sweden and Clinical Features of Familial Hemophagocytic Lymphohistiocytosis
|Acta Paediatrica|1991|449